Yu-ling Xiao, Xiao-jun Lu, M. Kang, Dongdong Li, Hong Jiang, Jie Chen, B. Ying, Yi Xie
{"title":"The management of biosafety risk in clinical laboratory of hospital during the outbreak of 2019 Novel Coronavirus disease/ 中华检验医学杂志","authors":"Yu-ling Xiao, Xiao-jun Lu, M. Kang, Dongdong Li, Hong Jiang, Jie Chen, B. Ying, Yi Xie","doi":"10.3760/CMA.J.CN114452-20200214-00070","DOIUrl":null,"url":null,"abstract":"During the outbreak of coronavirus disease-19 (COVID-19), the clinical laboratories of hospitals designated for the disease treatment is undertaking a lot of clinical testing work of infectious specimens. How to manage the biosafety risk is a major problem that the clinical laboratory and the nosocomial infection control department are facing. This article introduces the hierarchical prevention and control biosafety measures in the clinical laboratory from the perspective of the laboratory, with a view to provide reasonable and feasible methods for the clinical laboratories of hospitals at various levels during the outbreak. \n \nKey words: \nCoronavirus; Coronavirus infections; Severe acute respiratory syndrome; Communicable disease control","PeriodicalId":10096,"journal":{"name":"中华检验医学杂志","volume":"16 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华检验医学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.CN114452-20200214-00070","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Health Professions","Score":null,"Total":0}
引用次数: 0
Abstract
During the outbreak of coronavirus disease-19 (COVID-19), the clinical laboratories of hospitals designated for the disease treatment is undertaking a lot of clinical testing work of infectious specimens. How to manage the biosafety risk is a major problem that the clinical laboratory and the nosocomial infection control department are facing. This article introduces the hierarchical prevention and control biosafety measures in the clinical laboratory from the perspective of the laboratory, with a view to provide reasonable and feasible methods for the clinical laboratories of hospitals at various levels during the outbreak.
Key words:
Coronavirus; Coronavirus infections; Severe acute respiratory syndrome; Communicable disease control